These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38166733)

  • 1. Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.
    Mirzaei H; Eybpoosh S; Mehrabi F; Shojaei MR; Mirzazadeh A; Khezri M; Nasiri N; Sharifi H
    BMC Infect Dis; 2024 Jan; 24(1):29. PubMed ID: 38166733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
    J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
    Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E
    Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level of pre-treatment and acquired HIV drug resistance in Honduras: a nationally representative survey, 2016-17.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Meza RI; Sierra T; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Paredes M; Rodríguez A; Juárez SI; Farach N; Videa G; Lara B; Rodríguez E; Ardón E; Sajquim E; Lorenzana R; Ravasi G; Northbrook S; Reyes-Terán G; Ávila-Ríos S
    J Antimicrob Chemother; 2020 Jul; 75(7):1932-1942. PubMed ID: 32303063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016.
    Chen J; Liu Y; Liu S; Yuan D; Su L; Ye L; Gong F; Gao Y; Baloch S; Pei X
    Biomed Res Int; 2020; 2020():5894124. PubMed ID: 32280691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.
    Ismael N; Gemusse H; Mahumane I; Laurindo O; Magul C; Baxter C; Wilkinson E; Hofstra LM; Wagar N; Bila D; Mabunda N; da Silva J; Oliveira T; Raizes E; Preiser W; Manuel P; Ramos A; Vúbil A
    BMC Infect Dis; 2024 Jul; 24(1):748. PubMed ID: 39075381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmitted, pre-treatment and acquired antiretroviral drug resistance among men who have sex with men and transgender women living with HIV in Nigeria.
    Crowell TA; Kijak GH; Sanders-Buell E; O'Sullivan AM; Kokogho A; Parker ZF; Lawlor J; Polyak CS; Adebajo S; Nowak RG; Baral SD; Robb ML; Charurat ME; Ake JA; Ndembi N; Tovanabutra S;
    Antivir Ther; 2019; 24(8):595-601. PubMed ID: 32125280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.
    Aghokeng AF; Vergne L; Mpoudi-Ngole E; Mbangue M; Deoudje N; Mokondji E; Nambei WS; Peyou-Ndi MM; Moka JJ; Delaporte E; Peeters M
    Antivir Ther; 2009; 14(3):401-11. PubMed ID: 19474474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam.
    Thao VP; Le T; Török EM; Yen NT; Chau TT; Jurriaans S; van Doorn HR; de Jong MD; Farrar JJ; Dunstan SJ
    Antivir Ther; 2012; 17(5):905-13. PubMed ID: 22473024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.
    Crowell TA; Danboise B; Parikh A; Esber A; Dear N; Coakley P; Kasembeli A; Maswai J; Khamadi S; Bahemana E; Iroezindu M; Kiweewa F; Owuoth J; Freeman J; Jagodzinski LL; Malia JA; Eller LA; Tovanabutra S; Peel SA; Ake JA; Polyak CS;
    Clin Infect Dis; 2021 Oct; 73(7):e2311-e2322. PubMed ID: 32785695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Subtype Diversity and Factors Affecting Drug Resistance among Patients with Virologic Failure in Antiretroviral Therapy in Hainan Province, China, 2014-2020.
    Yu E; Xu YJ; Li M; Yang Y; Liang HY; Zhong SM; Qin C; Lan YN; Li DW; Yu JP; Pang Y; Qin XQ; Liang H; Zhu KK; Ye L; Liang BY
    Biomed Environ Sci; 2023 Sep; 36(9):800-813. PubMed ID: 37803893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.
    Bello G; Kagoli M; Chipeta S; Auld A; Chang JC; DeVos JR; Kim E; Mkungudza J; Payne D; Eliya M; Nyirenda R; Jahn A; Mzumara T; Mvula B; Dadabhai S; Namakhoma I; Babaye Y; Giron A; Jordan MR; Bertagnolio S; O'Malley G; Wadonda-Kabondo N
    Antivir Ther; 2022 Aug; 27(4):13596535221121225. PubMed ID: 35976773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients.
    Kiertiburanakul S; Chaiwarith R; Sirivichayakul S; Ditangco R; Jiamsakul A; Li PC; Kantipong P; Lee C; Ratanasuwan W; Kamarulzaman A; Sohn AH; Sungkanuparph S;
    PLoS One; 2013; 8(6):e62057. PubMed ID: 23826076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.
    Bokharaei-Salim F; Esghaei M; Khanaliha K; Kalantari S; Marjani A; Fakhim A; Keyvani H
    PLoS One; 2020; 15(3):e0229275. PubMed ID: 32119691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
    Segujja F; Omooja J; Lunkuse S; Nanyonjo M; Nabirye SE; Nassolo F; Bugembe DL; Bbosa N; Kateete DP; Ssenyonga W; Mayanja Y; Nsubuga RN; Seeley J; Kaleebu P; Ssemwanga D
    AIDS Res Hum Retroviruses; 2020 Sep; 36(9):782-791. PubMed ID: 32475121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China.
    Gao L; Xia H; Zeng R; Wu Y; Zaongo SD; Hu Y; Ma P
    HIV Med; 2022 Mar; 23 Suppl 1():84-94. PubMed ID: 35293099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon.
    Nzengui-Nzengui GF; Mourembou G; M'boyis-Kamdem H; Kombila-Koumavor AC; Ndjoyi-Mbiguino A
    BMC Infect Dis; 2024 Mar; 24(1):316. PubMed ID: 38486188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Level of HIV Drug Resistance and Virologic Nonsuppression Among Female Sex Workers in Ethiopia: A Nationwide Cross-Sectional Study.
    Arimide DA; Amogne MD; Kebede Y; Balcha TT; Adugna F; Ramos A; DeVos J; Zeh C; Agardh A; Chih-Wei Chang J; Björkman P; Medstrand P
    J Acquir Immune Defic Syndr; 2022 Apr; 89(5):566-574. PubMed ID: 34966147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018.
    Dat VQ; Anh NTL; Van Nghia K; Linh NT; Thu HHK; Tam TTM; Ton T; Anh LQ; Phuc ND; Huong PTT; Nhan DT; Hai NH; Bertagnolio S; Crisp AM; Inzaule S; Dean NE; Jordan MR; Nguyen VTT
    J Int AIDS Soc; 2022 Feb; 25(2):e25857. PubMed ID: 35194954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam.
    Bwire GM; Aiko BG; Mosha IH; Kilapilo MS; Mangara A; Kazonda P; Swai JP; Swalehe O; Jordan MR; Vercauteren J; Sando D; Temba D; Shao A; Mauka W; Decouttere C; Vandaele N; Sangeda RZ; Killewo J; Vandamme AM
    Sci Rep; 2023 Nov; 13(1):20493. PubMed ID: 37993493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.